HCAT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HCAT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Health Catalyst's enterprise value is $284.5 Mil. Health Catalyst's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $295.9 Mil. Therefore, Health Catalyst's EV-to-Revenue for today is 0.96.
The historical rank and industry rank for Health Catalyst's EV-to-Revenue or its related term are showing as below:
During the past 7 years, the highest EV-to-Revenue of Health Catalyst was 12.38. The lowest was 0.85. And the median was 4.87.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-04-25), Health Catalyst's stock price is $5.60. Health Catalyst's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.25. Therefore, Health Catalyst's PS Ratio for today is 1.07.
The historical data trend for Health Catalyst's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 7.08 | 9.60 | 7.62 | 1.71 | 1.59 |
Health Catalyst Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-Revenue | Get a 7-Day Free Trial | 1.71 | 1.92 | 2.15 | 1.65 | 1.59 |
For the Health Information Services subindustry, Health Catalyst's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Health Catalyst's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Health Catalyst's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 284.475 | / | 295.938 | |
= | 0.96 |
Health Catalyst's current Enterprise Value is $284.5 Mil.
Health Catalyst's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $295.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (NAS:HCAT) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Health Catalyst's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 5.60 | / | 5.246 | |
= | 1.07 |
Health Catalyst's share price for today is $5.60.
Health Catalyst's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Health Catalyst's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Linda Llewelyn | officer: Chief People Officer | C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121 |
Jason Alger | officer: Chief Accounting Officer | C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121 |
Benjamin Landry | officer: General Counsel | C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095 |
Matthew Kolb | director | C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095 |
Bryan Truman Hunt | officer: Chief Financial Officer | C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121 |
Daniel D. Burton | director, officer: Chief Executive Officer | C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121 |
Anne Marie Bickmore | officer: COO and Chief Product Officer | C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095 |
Kevin Lee Freeman | officer: Chief Growth Officer | C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095 |
Daniel H. Orenstein | officer: General Counsel | 311 ARSENAL STREET, WATERTOWN MA 02472 |
Duncan Gallagher | director | C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121 |
Paul Horstmeier | officer: Chief Operating Officer | C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121 |
Bryan Richard Hinton | officer: Chief Technology Officer | C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095 |
Nelli James Patrick Jr. | officer: Chief Financial Officer | C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121 |
Anita Pramoda | director | 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654 |
Timothy G. Ferris | director | C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121 |
From GuruFocus
By GuruFocus Research • 08-14-2023
By PRNewswire • 09-27-2023
By PRNewswire • 06-27-2023
By PRNewswire • 11-02-2023
By sperokesalga sperokesalga • 02-14-2023
By PRNewswire PRNewswire • 02-28-2023
By Marketwired • 07-24-2023
By Marketwired • 07-24-2023
By PRNewswire • 09-05-2023
By PRNewswire • 01-08-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.